Impact of 3D-Printed and Custom Mouthguards on Speech and Oral Functions in Children Practicing Contact Sports
Launched by CAIRO UNIVERSITY · May 7, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different types of mouthguards—traditional custom-made ones and newer, 3D-printed versions—affect speech and oral functions in children who play contact sports. Researchers want to see which type of mouthguard is more comfortable, fits better, and helps protect kids while they’re playing sports. The study will involve 60 children aged 8 to 14, and it will assess various factors like how well the mouthguards work, any changes in speech, and the overall cost over a year.
To be eligible for this trial, children need to be between 8 and 14 years old and actively participating in contact sports. They should also need a mouthguard for protection and be willing to cooperate during the study. However, children with certain speech or neurological issues, those undergoing specific orthodontic treatments, or those with serious dental problems won't be able to participate. This study aims to provide insights that could help improve mouthguard design and safety for young athletes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged 8-14 years of both ages.
- • Participants actively engaged in contact sports.
- • Children who require mouthguards for protection.
- • Cooperative children.
- Exclusion Criteria:
- • Children with a history of speech or neurological disorders affecting oral function
- • Parental refusal to participate.
- • Children currently undergoing orthodontic treatment with fixed appliances.
- • Presence of severe dental anomalies or extensive missing teeth that could interfere with mouthguard adaptation.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Gihan M Abuelniel, Doctoral Degree (Professor)
Study Director
Cairo University
Passant Nagi, Master's Degree
Study Director
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported